TP53 and cancer: Recent studies have considered Ras pathway alteration status in colorectal cancer [8]; alteration status across many cancer types in Ras genes [9, 10], TP53 [11], and PIK3CA [12]; and alteration status across cancer types in frequently mutated genes [13].